BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.7.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210326
DTEND;VALUE=DATE:20210327
DTSTAMP:20260430T034835
CREATED:20201126T144515Z
LAST-MODIFIED:20210319T083907Z
UID:25617-1616716800-1616803199@senzagen.com
SUMMARY:2021 SOT
DESCRIPTION:Booth #2062\nProgram\nThe official meeting time zone is US Eastern Daylight Time\, UTC -4. Please consult the World Time Zone Map for further guidance regarding the time conversions. \n\n\n\nMarch 16\n\n\n\n\n09:00am-10:00am\nExhibitor Hosted Session\, Booth #2062\n\n\n\n\nIn vitro skin sensitization testing for qualitative and quantitative potency assessment using GARD™\nDr Henrik Johansson\n\n\nMarch 23\n\n\n\n\n1:00pm – 2:45pm\nPoster Board # P323\n\n\n\n\nQuantitative Sensitizing Potency Assessment Using GARD Skin Dose-Response\nDr Henrik Johansson\n\n\n1:00pm – 2:45pm\nPoster Board # P322\n\n\n\n\nGARD Skin and GARD Potency: A Proof of Concept Study to Investigate the Applicability Domain for Agrochemical Formulations\nMarco Corvaro\, Corteva Agriscience\n\n\nMarch 24\n\n\n\n\n11:15am – 1:00pm\nPoster Board # P158\n\n\n\n\nApplicability Domain of the GARDskin Medical Device Test for In Vitro Skin Sensitization Testing of Medical Devices\nDr Rose-Marie Jenvert\n\n\n1:50pm – 2:20pm\nWorkshop 1287\n\n\n\n\nNovel In Vitro Assays for Sensitization Hazard Identification and Risk Assessment: Exploration of Chemical Space and Potential for Classifications of Difficult-to-Test Substances\nDr Andy Forreryd
URL:https://senzagen.com/event/2021-sot/
LOCATION:Virtual Meeting
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/11/SOT2021.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20210311T160000
DTEND;TZID=Europe/Stockholm:20210311T170000
DTSTAMP:20260430T034835
CREATED:20210216T124016Z
LAST-MODIFIED:20210217T124718Z
UID:23883-1615478400-1615482000@senzagen.com
SUMMARY:Nouvelle session – Cosmetic Safety 3.0 Webinaire France
DESCRIPTION:Webinaire en français (in French)\nParticipez à ce webinaire sur les nouvelles technologies in vitro utilisées pour l’évaluation des produits cosmétiques organisé par PKDerm\, GenEvolutioN et SenzaGen avec la participation de CEHTRA – experts en toxicologie. \nSuite au grand intérêt porté à la précédente édition de notre webinaire Cosmetic 3.0\, nous sommes ravis de vous convier à cette nouvelle session. Le webinaire débutera avec une présentation pré-enregistrée suivie par une session Questions-Réponses en direct. \n  \n \nProgramme\nÉvaluation des produits cosmétiques – pourquoi\, quand et comment? \nEfficacité: pénetration cutanée et inflammation (PKDerm) \nSécurité: toxicologie génétique appliquée aux produits naturels et aux produits de synthèse (GenEvolutioN) \nSécurité: sensibilisation cutanée\, le test génomique GARDskin (SenzaGen) \nSession questions-réponses \nConférenciers\n\n\nDr Hanan Osman-Ponchet\, Founder CEO & CSO\, PKDerm\n\nHanan Osman Ponchet est titulaire d’une maîtrise en toxicologie et pharmacologie ainsi que d’un doctorat en biochimie\, biologie céllulaire et moléculaire. Riche d’une expérience de 20 ans en développement pharmaceutique chez Sanofi et en charge du développement de nouveaux outils in vitro au sein de Galderma\, elle est la fondatrice et PDG de la société PKDERM spécialisée dans les tests in vitro pour évaluer l’efficacité et la sécurité des produits cosmétiques et pharmaceutiques. \n\n\nFrancis Finot\, Co-Founder\, GenEvolutioN\n\nFrancis Finot est titulaire d’un Master en pharmacologie cellulaire et toxicologie. Fort d’une longue carrière dans l’industrie pharmaceutique chez Sanofi et en tant que directeur d‘études chez Covance\, il est expert dans le domaine de la génotoxicité et de la sécurité des produits chimiques\, cosmétiques et pharmaceutiques. Francis est co-fondateur et président de GenEvolutioN\, une société créée en 2017\, dédiée à l’expertise en toxicologie génétique et toxicologie in vitro utilisant des nouveaux modèles de cellules humaines. \n\n\nDr Clarisse Bavoux\, Toxicologist\, Regulatory Responsible\, CEHTRA\n\nClarisse BAVOUX est pharmacienne\, titulaire d’un DEA en Toxicologie et d’un doctorat en biologie de l’université Toulouse III. Elle est inscrite au registre européen des toxicologues (ERT) depuis 2012. Clarisse a exercé la toxicologie réglementaire à l’INRS\, à l’AFSSA\, puis à l’ANSM. Depuis 2011\, elle assure le rôle d’évaluateur de la sécurité pour différentes sociétés et tous types de produits cosmétiques. Chez CEHTRA depuis 2017\, elle coordonne l’activité de conseil du développement de l’ingrédient ou du produit cosmétique à la rédaction du rapport final\, jusqu’au suivi du produit lors de sa commercialisation. \n\n\nAnna Chérouvrier Hansson\, VP Business Development\, SenzaGen\n\nAnna Chérouvrier Hansson est diplômée de l’école de commerce de Reims et titualire d’une maîtrise en affaires européennes de l’Université de Lund (Suède). Depuis plus de vingt ans\, elle a occupé des postes en marketing\, ventes et stratégie commerciale au sein de l’industrie des sciences de la vie. En charge du développement d’affaires\, elle est responsable pour les activités commerciales de la société SenzaGen. Francophone\, elle gère également les activités déployées avec nos partenaires français.
URL:https://senzagen.com/event/cosmetic-safety-3-0-webinaire-france-in-french-en-francais/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2021/02/cropped-banner-v1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20210225T160000
DTEND;TZID=Europe/Stockholm:20210225T170000
DTSTAMP:20260430T034835
CREATED:20210209T094609Z
LAST-MODIFIED:20210209T094609Z
UID:25771-1614268800-1614272400@senzagen.com
SUMMARY:Webinar: How is GARD™ used for sensitization testing?
DESCRIPTION:User cases on hazard and potency assessment\nJoin us for this free webinar to get the latest news about the in vitro GARD™ assays and how they are used across various industries to fill data gaps in sensitizing hazard and potency assessment of chemicals and medical devices. \n\nKey topics\nWe will provide several user cases on how the GARD assays have been used for skin sensitization testing to demonstrate: \n\nHazard assessment of “difficult-to-test” samples such as complex mixtures and surfactants.\nSensitization information for risk assessment of medical devices and solid materials.\nPotency determination for both CLP classification and product development.\n\nThe webinar should last around 30 minutes\, followed by a live Q&A. If you cannot attend the live event\, register now to get access to the recording of this webinar. \nFeatured speaker\nRose-Marie Jenvert\, PhD Product Manager GARD applications\, SenzaGen AB \nDr Jenvert is responsible for managing new GARD applications and supporting customer needs with our GARD technology for skin and respiratory sensitization testing. She has extensive knowledge in biocompatibility testing of medical devices and acts as an expert in ISO/TC194 WG8\, updating the standards for skin sensitization and skin irritation (ISO 10993-10 and -23). \n  \nRead more and register
URL:https://senzagen.com/event/webinar-how-is-gard-used-for-sensitization-testing/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2021/02/Webinar-how-is-GARD-used-20210209-cropped-v2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20210127T160000
DTEND;TZID=Europe/Stockholm:20210127T164500
DTSTAMP:20260430T034835
CREATED:20210112T153543Z
LAST-MODIFIED:20210112T153543Z
UID:25716-1611763200-1611765900@senzagen.com
SUMMARY:Webinar: Why choose GARD™ for sensitization testing?
DESCRIPTION:In vitro\, high accuracy\, broad applicability\nJoin this free webinar to learn how the GARD™ assays\, based on genomics and machine learning\, provide a highly accurate method for skin sensitization hazard and potency assessment of chemicals\, including “difficult-to-test” substances. \n\n\nKey topics:\n\nAn introduction to the prediction model\, genomics and machine learning technology\nThe broad applicability and high accuracy of the GARD assays\nSeveral applications and case studies\n\nThe webinar will last around 30 minutes\, followed by a live Q&A. If you can’t attend the live event\, register now to get access to the recording of this webinar. \n  \nFeatured speakers\nAndy Forreryd\, PhD\, Scientific Liaison\, SenzaGen                          Henrik Johansson\, PhD\, Chief Scientist\, SenzaGen \nRead more and register
URL:https://senzagen.com/event/webinar-why-choose-gard-for-sensitization-testing/
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2021/01/Webinar-Why-choose-GARD-2021-01-27-v2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20201201T190000
DTEND;TZID=Europe/Stockholm:20201202T233000
DTSTAMP:20260430T034835
CREATED:20200904T081245Z
LAST-MODIFIED:20201029T072034Z
UID:24701-1606849200-1606951800@senzagen.com
SUMMARY:STC Symposium 2020
DESCRIPTION:Dec. 1st at 1:10pm EDT \nAs part of the “Sensitization: Skin & Beyond” science panel\, Dr. Andy Forreryd at SenzaGen will be presenting a talk titled: “The GARD Platform for Skin and Respiratory Sensitization Testing: Practical Applications and Case Studies”. \n  \nDon’t miss Andy’s talk and register today!
URL:https://senzagen.com/event/stc-symposium-2020/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/11/stc1-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20201126T130000
DTEND;TZID=Europe/Stockholm:20201126T160000
DTSTAMP:20260430T034835
CREATED:20200922T090609Z
LAST-MODIFIED:20201118T124806Z
UID:24863-1606395600-1606406400@senzagen.com
SUMMARY:Workshop: In vitro methods in practice
DESCRIPTION:This day is offering a theoretical base with different lectures on research forefront and financing opportunities. The workshop originally included a practical session on site\, but due to the covid-19 situation this session must be postponed. \nResearchers from different universities\, research institutes and companies are participating in the program\, that will last from 1 PM to 4 PM (Central European Time)\, 13-16 (Swedish time). The entire program will be held in English. \nRegister\nRegister for the workshop on November 26th \nProgram\nWelcome – the Swedish 3Rs Center \nIn vitro methods as animal replacements\n\nAn animal free human tumour outside the body for testing of potential anti-cancer compounds\, Stina Oredsson\, Lund University\nMoving away from animal experimentation for acute inhalation toxicity testing\, Emelie Da Silva\, National Research Centre for Working Environment\, Denmark\n\nAnimal free allergy testing using genomics and AI\, Olivia Larne\, Senzagen \n\n\nState-of-the-art in vitro techniques\n\nMicromachined 3D culture scaffolds\, Maria Tenje\, Uppsala University\nMicrofluidic single-cell technologies for disease modeling and drug discovery\, Samareh Gharaei\, Fluicell\nGood in vitro method practices\, Kristina Fant\, RISE
URL:https://senzagen.com/event/workshop-in-vitro-methods-in-practice/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2020/09/3R-logotyp-höger-bättre.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20201116T080000
DTEND;TZID=Europe/Stockholm:20201116T170000
DTSTAMP:20260430T034835
CREATED:20200904T074150Z
LAST-MODIFIED:20201115T183357Z
UID:24697-1605513600-1605546000@senzagen.com
SUMMARY:ACT 2020 Annual Meeting
DESCRIPTION:Monday November 16\, 2020 \n\n\n\n5:00 PM–6:30 PM EST\nVirtual Poster Session: \nDose-Response Analysis in GARD for Assessment of Skin Sensitizer Potency \nApplicability of GARDskin for Accurate Assessment of Challenging Substances in the Context of Skin Sensitization Testing
URL:https://senzagen.com/event/act-2020-annual-meeting/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/09/act_am20_logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201030
DTEND;VALUE=DATE:20201031
DTSTAMP:20260430T034835
CREATED:20201014T092354Z
LAST-MODIFIED:20201014T092425Z
UID:25379-1604016000-1604102399@senzagen.com
SUMMARY:NURA 2020 Virtual Symposium
DESCRIPTION:New Approach Methodology Use for Regulatory Application (NURA) in collaboration with the Association for the Advancement of Alternatives Assessment (A4) is hosting two half day trainings to explore practical solutions for the safety assessment of cosmetics and consumer products. Lectures\, discussions\, and demonstrations will help attendees evaluate the advantages of new nonanimal approaches and apply them to a range of consumer and occupational health needs. \nFriday\, October 30\, 2020  \n\n\n\n9:55 am\nThe GARDskin Assay for Skin Sensitization Hazard Identification and Quantitative Potency Assessments: Practical Applications and Case Studies\nAndy Forreryd\, SenzaGen\n\n\n\nRegister for the NURA Short Courses on the Symposium registration page.
URL:https://senzagen.com/event/nura-2020-virtual-symposium/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2020/10/20574-TOX-NURA-for-Consumer-Products-Training-Graphic_FB_Twitter.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201028
DTEND;VALUE=DATE:20201029
DTSTAMP:20260430T034835
CREATED:20200904T073758Z
LAST-MODIFIED:20201014T104011Z
UID:24694-1603843200-1603929599@senzagen.com
SUMMARY:BioInterface 2020 – Workshop & Symposium
DESCRIPTION:Wednesday\, October 28\, 2020 \n\n\n\n\n\n\n\n\n11:05 a.m. PT \n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\nJoshua Schmidt\, SenzaGen\, Inc.\n“Leveraging in vitro to forecast in vivo success”
URL:https://senzagen.com/event/biointerface-2020-workshop-symposium/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/09/logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20201021T160000
DTEND;TZID=Europe/Stockholm:20201021T170000
DTSTAMP:20260430T034835
CREATED:20200911T144921Z
LAST-MODIFIED:20200921T162913Z
UID:24756-1603296000-1603299600@senzagen.com
SUMMARY:Webinar: Safer Medical Devices
DESCRIPTION:In Vitro Skin Sensitization Testing with Human Relevance and High Accuracy\nIn this webinar you will learn how combining genomics and machine learning provides a highly accurate in vitro method for assessment of skin sensitization hazard in medical device extracts\, prepared according to ISO 10993-12. \n\n\nWhat You Will Learn\nAttendees will gain insights into: \n\nHow GARD™skin Medical Device works and why it is highly accurate and human-relevant\nHow to predict skin sensitizing hazard of materials by testing extractables directly using extraction solvents in accordance with ISO 10993:12\nHow customers use the study results in different stages of the product life cycle\, for safer products and in line with the 3Rs\n\n\nWho Should Attend?\nThis webinar will benefit professionals working in the medical device industry\, including: \n\nDecision Makers\nSafety Specialists\nBiocompatibility Experts\nToxicologists\n\nThis will also be relevant to consultant companies and CROs specializing in biological evaluation and biocompatibility testing.   \n  \nSpeakers\n            \n\n\nDr Rose-Marie Jenvert:   Product Manager GARD applications\n\n\nDr Joshua Schmidt:   Business Development Director-Americas\n\n\n  \nRead more and register
URL:https://senzagen.com/event/webinar-safer-medical-devices-in-vitro-skin-sensitization-testing-with-human-relevance-and-high-accuracy/
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/09/Banner-cropped-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20201020T080000
DTEND;TZID=Europe/Stockholm:20201022T170000
DTSTAMP:20260430T034835
CREATED:20200903T075537Z
LAST-MODIFIED:20201014T092658Z
UID:24688-1603180800-1603386000@senzagen.com
SUMMARY:ASCCT 9th Annual Meeting + Training
DESCRIPTION:Senzagen will be presenting a poster at the ASCCT meeting on Oct 20 from 4:45-6 pm EDT.  \nCome join us to learn about how the GARDskin Dose-Response assay can be used for quantitative potency assessment!
URL:https://senzagen.com/event/ascct-9th-annual-meeting-training/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/09/ascct-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20200924T080000
DTEND;TZID=Europe/Stockholm:20200925T170000
DTSTAMP:20260430T034835
CREATED:20200903T075308Z
LAST-MODIFIED:20200923T075910Z
UID:24681-1600934400-1601053200@senzagen.com
SUMMARY:Biocompatibility testing in Medical Devices Conference 2020
DESCRIPTION:Biocompatibility testing in Medical Devices Conference 2020 will give you the unique opportunity to discuss the most pressing issues and meet the representatives of the biggest companies and leaders from Biocompatibility and Medical Device Industries \nBiocompatibility testing in Medical Devices Conference 2020 is a great platform for learning\, exchanging opinions\, and expanding one’s network enabled by live presentations followed by dynamic questions & answers sessions as well as panel discussions and workshops with keynote speakers. \n\nSpeaker: PhD Rose-Marie Jenvert\, SenzaGen:\nIn vitro alternatives for assessment of skin irritation and skin sensitization potential of chemicals in medical devices
URL:https://senzagen.com/event/biocompatibility-testing-in-medical-devices-conference-2020/
LOCATION:Prague
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/09/Biocom.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20200922T130000
DTEND;TZID=Europe/Stockholm:20200922T140000
DTSTAMP:20260430T034835
CREATED:20200922T091043Z
LAST-MODIFIED:20200922T091143Z
UID:24871-1600779600-1600783200@senzagen.com
SUMMARY:OpenTox Virtual Conference
DESCRIPTION:13.00 Session 5. Cosmetics Assessment \n\nChair: Hanan Osman-Ponchet (PKDERM)\nTalk: Andy Forreryd\,  Dose-response analysis in GARD for assessment of skin sensitizer potency
URL:https://senzagen.com/event/opentox-virtual-conference/
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/09/OT-banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20200915T160000
DTEND;TZID=Europe/Stockholm:20200915T163000
DTSTAMP:20260430T034835
CREATED:20200716T065215Z
LAST-MODIFIED:20200716T065215Z
UID:24122-1600185600-1600187400@senzagen.com
SUMMARY:Joint webinar: Your Guide to GARD® – New generation skin sensitisation testing technologies explained
DESCRIPTION:SenzaGen have partnered with XCellR8 to bring you this half hour webinar to explain more about how the GARD methods work\, from determining potency to animal-product-free solutions. \n \nYou will learn\n\nHow GARD assays can be used for the safety assessment of chemicals\, formulations and finished products\nHow the new animal-product-free version of GARDskin can help support vegan tested claims\nHow GARD is meeting the challenges of skin sensitisation potency and dose-response\n\nSpeakers\n         \nDr Carol Treasure\, XCellR8     Dr Andy Forreryd\, SenzaGen\nWho should attend?\nThis webinar is designed for anyone involved in cosmetic product development\, including formulators\, regulatory managers\, safety assessors and toxicologists. You don’t need a technical background on genomics\, machine learning or programming.
URL:https://senzagen.com/event/joint-webinar-your-guide-to-gard-new-generation-skin-sensitisation-testing-technologies-explained/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2020/07/Sep-15_Banner_event-page.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20200909T150000
DTEND;TZID=Europe/Stockholm:20200909T163000
DTSTAMP:20260430T034835
CREATED:20200903T074926Z
LAST-MODIFIED:20200904T104225Z
UID:24675-1599663600-1599669000@senzagen.com
SUMMARY:MVA\, MedTech Network
DESCRIPTION:MVA Medtech Network gathers the region’s medtech industry to create new partnerships and business opportunities. Joining the network is free of charge but is limited to Medicon Valley Alliance members. However\, non-member organizations and companies are welcome to attend one network event to evaluate if being part of the network is relevant. If so\, becoming a member of Medicon Valley Alliance will automatically allow you to join the medtech network. \nProgram\n \n\n\n\n14.50-15.00\nOnline platform open for registering participants\n\n\n15.00-15.10\nWelcome\nPetter Hartman\, CEO\, Medicon Valley Alliance\n\n\n15.10-15.30\n21st Century Toxicology: Alternatives for Medical Device Testing\nKelly P. Coleman\, Distinguished Toxicologist\, Medtronic PLC\n\n\n15.30-15.40\nComputational methods\nCarsten Baun Senholt\, CTO\, Saxocon\n\n\n15.40-15.50\nNew in vitro test methods\nRose-Marie Jenvert\, Product Manager GARD applications\, Senzagen\n\n\n15.50-16.10\nConsiderations and points of interest of notified bodies for medical devices with regard to in-silico approaches for toxicological risk assessment\nJulian Kirch\, General Essential Modules – TÜV SÜD Product Service GmbH\n\n\n16.10-16.15\nConclusions\nCompany TBC
URL:https://senzagen.com/event/mva-medtech-network/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/09/MVA.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20200903T160000
DTEND;TZID=Europe/Stockholm:20200903T163000
DTSTAMP:20260430T034835
CREATED:20200818T102204Z
LAST-MODIFIED:20200825T083659Z
UID:24195-1599148800-1599150600@senzagen.com
SUMMARY:New session: Webinar GARD™skin Dose-Response
DESCRIPTION:Given the huge interest in our previous webinar on GARDskin Dose-Response\, we are pleased to offer you a new opportunity to get to know this novel in vitro test. \nThe webinar will start with a recorded presentation followed by a live Q&A session. You will learn how the assay works and how it can help you with skin sensitizing potency ranking of candidate ingredients and early decision-making during product development.\n \n\nKey takeaways\n\nHow GARDskin Dose-Response works.\nHow the readouts correlate with LLNA EC3 values and human sensitizing potency categories.\nExamples of how the readout can be used depending on the customer-specific needs.\n\n  \n \nFeatured Speaker\n \nAndy Forreryd\, PhD\, SenzaGen AB \nGARDskin Dose-Response at a glance\nGARDskin Dose-Response is a novel in vitro test for quantitative potency assessment of chemicals\, adapted from GARDskin. \nGARDskin Dose-Response provides an estimated threshold concentration for a test substance to induce skin sensitizing effects (higher equaling a lower potency and vice versa). This threshold concentration can be used for skin sensitizing potency ranking of candidate ingredients and early decision-making during product development. \nAdditionally\, the readout can be extrapolated to a correlating LLNA EC3 value\, which is traditionally used to measure skin sensitizing potency of chemicals. Depending on the customer needs\, it can also be extrapolated to a correlating Basketter Human Potency category (1-6) and/or GHS/CLP classification (1A or 1B) with high statistical significance. \n\nRead more\n\n\n\n  \n\nWhat to know before attending the webinar?\nThe webinar will last around 30 minutes\, followed by a live Q&A. \nNo required technical background on genomics\, machine learning or programming. \nIf you can’t attend\, still make sure to register! All registrants will receive the webinar materials afterwards.
URL:https://senzagen.com/event/new-session-gardskin-dose-response/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2020/08/Webinar_Banner_Linkedin.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200617
DTEND;VALUE=DATE:20200618
DTSTAMP:20260430T034835
CREATED:20200602T155406Z
LAST-MODIFIED:20200603T061943Z
UID:22722-1592352000-1592438399@senzagen.com
SUMMARY:Web-based launch: The NEW GARDskin Dose-Response
DESCRIPTION:If you’re interested in quantitative potency assessment of your product\, listen in and learn how GARDskin Dose-Response threshold concentrations can be linked to LLNA´s EC3 values and human sensitizing potency. \n\nWhat You Will Learn\nIn this webinar\, attendees will gain insights into: \n\nHow GARDskin Dose-Response studies provide information to establish safety thresholds for different substances.\nHow the threshold concentrations correlate with LLNA’s EC3 values and human sensitizing potency.\nExamples of how the readout can be used depending on the customer specific needs.\n\n  \n \nFeatured Speaker\n \nAndy Forreryd\, PhD\, SenzaGen AB \nHigh information\, high accuracy\nThe GARD tests are developed by combining genomic data from a relevant human cell type with machine learning to create a prediction model for identification of chemical sensitizers. This holistic\, cell-based\, high-information approach provides prediction accuracy exceeding 90% for skin sensitization. \nWith its high accuracy\, demonstrated human relevance and broad applicability\, the GARD assay platform can support your specific test requirements.
URL:https://senzagen.com/event/web-based-launch-the-new-gardskin-dose-response/
LOCATION:4.00pm CEST | 10.00am EDT
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/06/17june_Banner_Linkedin.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20200526T160000
DTEND;TZID=Europe/Stockholm:20200526T170000
DTSTAMP:20260430T034835
CREATED:20200424T140342Z
LAST-MODIFIED:20200506T063836Z
UID:22203-1590508800-1590512400@senzagen.com
SUMMARY:Webinar: Genomics and Machine Learning for In Vitro Sensitization Testing of Challenging Chemicals
DESCRIPTION:In this webinar\, attendees will learn how genomics and machine learning can provide a highly accurate method for both skin and respiratory sensitization assessment of chemicals\, including “difficult-to-test” substances. \n\nWho Should Attend?\nDecision Makers and Toxicologists within the Chemical industry. Typical roles for the Decision Makers could be related to R&D\, Product Development\, Quality & Regulatory and CSR. \n\n\nWhat You Will Learn\nIn this webinar\, attendees will gain insights into: \n\nHow to optimize in vitro testing strategies for safer products and cost savings\nHow the GARD assays’ high accuracy\, demonstrated human relevance and broad applicability can support specific testing needs\, including “difficult-to-test” substances\nHow the GARD technology platform works and why it is highly accurate – the prediction model\, genomics and machine learning technology\nHow customers across the chemical industry use the assays for skin and respiratory sensitization testing. Get insights from industry partners from several applications and case studies\n\nRead more and register\n \nSpeakers\n\nAndy Forreryd\, PhD\, SenzaGen AB\nHenrik Johansson\, PhD\, Chief Scientist\, SenzaGen AB
URL:https://senzagen.com/event/webinar-genomics-and-machine-learning-for-in-vitro-sensitization-testing-of-challenging-chemicals/
LOCATION:Xtalks
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/04/Xtalks.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200326
DTEND;VALUE=DATE:20200327
DTSTAMP:20260430T034835
CREATED:20200320T161628Z
LAST-MODIFIED:20200323T075750Z
UID:22110-1585180800-1585267199@senzagen.com
SUMMARY:Web-based conference on “Difficult-to-test” substances and regulatory testing
DESCRIPTION:Join SenzaGen’s web-based conference on “Difficult-to-test” substances and regulatory testing in place of our exhibitor hosted session at SOT 2020\nTake this chance and participate in our web-based conference on the latest news about GARD™ and how customers use the assays for skin and respiratory sensitization testing. \nKey takeaways\n\nInsights on sensitization assessment of “difficult-to-test” substances\nExperiences on how to use GARD for regulatory testing\nResults from industry partners from several applications and case studies\nUpdates on the GARD assays by SenzaGen experts\n\nSpeakers\n\nAndy Forreryd\, SenzaGen AB\nCharles Humfrey/Yafan Li/Len Sweet: Collaborators at the Lubrizol Corporation.\nHelge Gehrke\, Eurofins BioPharma Product Testing\nGeorge DeGeorge\, MB Research Labs\n\nAvailable on two occasions\nEU Time Zone | Mar 26\, 11:00 CET | Register here\nUS Time Zone | Mar 26\, 11:00 EDT | Register here
URL:https://senzagen.com/event/web-based-conference-on-difficult-to-test-substances-and-regulatory-testing/
LOCATION:Available on two occasions\, EU Time Zone | 11:00 CET\, US Time Zone | 11:00 EDT
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2020/03/Final_March_Banner_Linkedin.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200319
DTEND;VALUE=DATE:20200320
DTSTAMP:20260430T034835
CREATED:20200312T103421Z
LAST-MODIFIED:20200312T103421Z
UID:22095-1584576000-1584662399@senzagen.com
SUMMARY:Web-based SOT 2020 poster presentation session
DESCRIPTION:Join SenzaGen’s free web-based SOT 2020 poster presentation session\nDon’t miss the opportunity to participate in our web-based conference on the latest news about the GARD™ assays for skin and respiratory sensitization testing. \nKey takeaways\n– Comparative study: GARDskin for challenging substances\n– How to test UVCBs and Mixtures\n– Formal validation of GARDpotency for subclassification of skin sensitizers\n– GARDair technology update and case study \nAvailable on two occasions \nEU Time Zone | Mar 19\, 11:00 CET | Register here\nUS Time Zone | Mar 19\, 11:00 EDT | Register here\nDo you have challenging samples?\nComplex mixtures\, natural extracts or other low solubility substances – what are your difficult-to-test samples? GARD is a genomic-based in vitro test with high performance and broad applicability specializing in difficult-to-test samples that can help you through the hurdles in your product life cycle. Hundreds of samples have been tested and successfully reported. 
URL:https://senzagen.com/event/web-based-sot-2020-poster-presentation-session/
LOCATION:Available on two occasions\, EU Time Zone | 11:00 CET\, US Time Zone | 11:00 EDT
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2020/03/1_SOT_Banner_Linkedin.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200315
DTEND;VALUE=DATE:20200320
DTSTAMP:20260430T034835
CREATED:20191209T093948Z
LAST-MODIFIED:20200304T091342Z
UID:21698-1584230400-1584662399@senzagen.com
SUMMARY:SOT Annual Meeting 2020
DESCRIPTION:Join SenzaGen’s hosted session at the SOT Annual Meeting and ToxExpo\nWill you be at SOT in Anaheim in March? Come join our hosted session to hear the latest news about GARD™ and how customers use the assays for skin and respiratory sensitization testing. We will show results from several case studies. \nHosted session\nTue\, Mar 17 at 1:30pm – 2:30pm | Room 206B\nThe Application of In Vitro GARD™ Assays for Skin and Respiratory Sensitization Assessment of “Difficult-to-Test” Substances \nSpeakers\n– Dr. Andy Forreryd\, SenzaGen AB\n– Drs. Charles Humfrey/Yafan Li/Len Sweet: Collaborators at the Lubrizol Corporation.\n– Dr. George DeGeorge\, MB Research Labs \nNo registration needed. \nWe are in booth #869 – book a meeting with us!\nYou can also meet us at our posters\nID 1180 | Board no P225 | CC Exhibit Hall | Mon\, Mar 16 at 10:45am – 12:30pm\nInter-Laboratory Ring Trial of the GARD Air Assay for Assessment of Respiratory Sensitizers—Results of Predictive Performance and Reproducibility \nID 2369 | Board no P790 | CC Exhibit Hall | Tue\, Mar 17 at 9:00am – 10:45am\nFormal Validation of the GARDpotency Assay for Subclassification of Chemical Skin Sensitizers—Ring Trial Results of Predictive Performance and Reproducibility \nID 2372 | Board number P793 | CC Exhibit Hall | Tue at Mar 17\, 9:00am – 10:45am\nApplicability of GARDskin for Accurate Assessment of Challenging Substances in the Context of Skin Sensitization Testing \nID 2808 | Board number P425 | CC Exhibit Hall | Wed\, Mar 18 at 2:15pm – 4:30pm\nEstimating the Sensitivity of GARDskin and GARDair Assays for Evaluating Skin and Respiratory Sensitization Potential of Complex Mixtures; An Initial Case Study Using Spiked E-liquids \nID 3418 | Board no P232 | CC Hall C | Thu\, Mar 19 at 8:30am – 11:30am\nExtended Applicability Domain of the GARD Platform by Solvent-Extraction Protocols Allows for Accurate Assessment of Sensitizing Mixtures and UVCBs
URL:https://senzagen.com/event/sot-annual-meeting-2020/
LOCATION:Anaheim\, CA
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/12/SOT2020.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200225
DTEND;VALUE=DATE:20200226
DTSTAMP:20260430T034835
CREATED:20200206T094818Z
LAST-MODIFIED:20200211T161137Z
UID:21979-1582588800-1582675199@senzagen.com
SUMMARY:Free webinar: In vitro sensitization testing based on genomics and machine learning
DESCRIPTION:All you need to know about the GARD™ assays for skin and respiratory sensitization testing \nDid you miss our popular webinar ‘GARD technology: Genomics and Machine Learning’ last year? Here is a new opportunity to participate in a live webinar presented by GARD experts at SenzaGen followed by a Q&A session. \nJoin us and you’ll learn the principles of the technology platform and get an updated overview of its broad applicability. This webinar will give you in-depth knowledge about GARD. \nKey takeaways \n\nThe story behind the development of the technology platform\nHow the platform works and why it is highly accurate – the prediction model\, genomics and machine learning technology\nApplicability of the GARD assays – what chemicals have been tested? How about complex mixtures\, natural extracts and low solubility substances?\n\nAvailable on two occasions \nEU Time Zone | Feb 25\, 11:00 CET | Register here\nUS Time Zone | Feb 25\, 11:00 EST| Register here \n 
URL:https://senzagen.com/event/free-webinar-in-vitro-sensitization-testing-based-on-genomics-and-machine-learning/
LOCATION:Available on two occasions\, EU Time Zone | 11:00 CET\, US Time Zone | 11:00 EDT
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2020/02/Banner_Linkedin_webinar_bullets.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191211
DTEND;VALUE=DATE:20191213
DTSTAMP:20260430T034835
CREATED:20191121T074358Z
LAST-MODIFIED:20191126T083205Z
UID:21610-1576022400-1576195199@senzagen.com
SUMMARY:PCRM's NURA Training
DESCRIPTION:Integrating Modern Science Approaches \nSpeaker: Joshua Schmidt\, PhD. GARD as part of Integrated Strategy. \n 
URL:https://senzagen.com/event/pcrms-nura-training/
LOCATION:Houston\, TX
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/11/NURA-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191202
DTEND;VALUE=DATE:20191205
DTSTAMP:20260430T034835
CREATED:20191122T163706Z
LAST-MODIFIED:20191129T072428Z
UID:21621-1575244800-1575503999@senzagen.com
SUMMARY:The Society of Toxicology of Canada 51th Annual Symposium
DESCRIPTION:
URL:https://senzagen.com/event/the-society-of-toxicology-of-canada-51th-annual-symposium/
LOCATION:Ottawa\, Canada
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/11/stc1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191117
DTEND;VALUE=DATE:20191121
DTSTAMP:20260430T034835
CREATED:20190917T150236Z
LAST-MODIFIED:20190917T150236Z
UID:20223-1573948800-1574294399@senzagen.com
SUMMARY:ACT 40th Annual Meeting
DESCRIPTION:The 40th Annual Meeting will include a wide-ranging scientific program\, a welcome reception\, the popular traditional poster session reception\, an awards ceremony and luncheon\, distinguished plenary speakers\, and numerous professional networking events.
URL:https://senzagen.com/event/act-40th-annual-meeting/
LOCATION:Phoenix\, Arizona\, USA
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/09/ACT2019.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191106
DTEND;VALUE=DATE:20191108
DTSTAMP:20260430T034835
CREATED:20190917T142949Z
LAST-MODIFIED:20190918T063533Z
UID:20214-1572998400-1573171199@senzagen.com
SUMMARY:Training: In Vitro Assays Development & Good In Vitro Method Practices
DESCRIPTION:This training will illustrate various aspects of the OECD Good In Vitro Methods Practices (GIVIMP) guidance document (STA 286) using assays/techniques/test systems that have been developed recently by the different trainers. It aims to provide the participants with hands-on\, practical skills in how to apply GIVIMP in their daily work in the laboratory\, and at the same time learn about modern techniques used for in vitro testing. \nHands-on Training with SenzaGen \nNov 6\, 2019 \n14:00 – 14:30 Hands-on Training\ngroup B : Solubility / Rose Marie Jenvert – SenzaGen \n14:30 – 15:00 Hands-on Training\ngroup A : Solubility / Rose Marie Jenvert – SenzaGen
URL:https://senzagen.com/event/in-vitro-assays-development-good-in-vitro-method-practices/
LOCATION:Gothenburg\, Sweden
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/09/cropped-altertox_academy_logo-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191104
DTEND;VALUE=DATE:20191106
DTSTAMP:20260430T034835
CREATED:20190918T064832Z
LAST-MODIFIED:20190918T064832Z
UID:20231-1572825600-1572998399@senzagen.com
SUMMARY:Le congrès annuel de la SFT
DESCRIPTION:Nouveaux Modèles\, Nouvelles Approches\, Nouveaux Défis en Évaluation du Risque \nProgramme Nov 4 2019 \n14 h 45 – 15 h 15 Nouveaux modèles en sensibilisation in vitro \n2. In vitro assessment of respiratory sensitisation: the GARDair test\nAndy FORRERYD\, SenzaGen\, Lund (Suède) \nFull programme
URL:https://senzagen.com/event/le-congres-annuel-de-la-sft/
LOCATION:Paris\, France
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/09/logo_sft.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191023
DTEND;VALUE=DATE:20191024
DTSTAMP:20260430T034835
CREATED:20190918T155444Z
LAST-MODIFIED:20191002T063647Z
UID:20273-1571788800-1571875199@senzagen.com
SUMMARY:Free webinar: In vitro skin sensitization testing of Medical Devices
DESCRIPTION:GARD™skin Medical Device – All you need to know about the GARD™ technology for in vitro sensitization testing of Medical Devices\nJoin Dr Rose-Marie Jenvert from SenzaGen for a webinar on how the in vitro GARD™skin Medical Device can be used for skin sensitization testing of polar and non-polar extractions of Medical Devices. \nKey takeaways\n\nHow GARD™skin Medical Device can be used for skin sensitization testing of Medical Devices.\nUse of polar and non-polar extraction vehicles.\nCase studies showing how GARD™skin Medical Device be used during product development\, for final products and during product life cycle.\n\nAvailable on two occasions\nEU Time Zone | 23 Oct\, 15:00 CET | Registration\nUS Time Zone | 23 Oct\, 13:00 EDT| Registration
URL:https://senzagen.com/event/free-webinar-in-vitro-skin-sensitization-testing-of-medical-devices/
LOCATION:Available on two occasions\, EU Time Zone | 11:00 CET\, US Time Zone | 11:00 EDT
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2019/09/Webinar_Banner_Linkedin.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191001
DTEND;VALUE=DATE:20191003
DTSTAMP:20260430T034835
CREATED:20190904T151004Z
LAST-MODIFIED:20190925T120839Z
UID:20057-1569888000-1570060799@senzagen.com
SUMMARY:The 3rd Symbioteq Biocompatibility of Medical Devices Conference 2019
DESCRIPTION:The conference gives you the opportunity for learning the latest news within biocompatibility together with excellent networking\, being a specialist or beginner within biocompatibility/toxicology? Product safety\, material specialist\, within material characterization\, for those of you in development\, production\, process development or Quality Assurance/Regulatory Affairs\, we are sure you will have a rewarding few days in Gothenburg. \nProgram Oct 1\n14.00\nThird session: In Vitro Methods\, Progress and Hurdles\nCo-chair: Rose-Marie Jenvert PhD\, Product Manager\, SenzaGen\, Sweden. Member of SIS/TC 340 and Swedish expert in ISO TC 194 \nLink to full program
URL:https://senzagen.com/event/the-3rd-symbioteq-biocompatibility-of-medical-devices-conference-2019/
LOCATION:Gothenburg\, Sweden
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2019/09/Biocompatibility.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190925
DTEND;VALUE=DATE:20190926
DTSTAMP:20260430T034835
CREATED:20190821T125536Z
LAST-MODIFIED:20190918T160256Z
UID:19919-1569369600-1569455999@senzagen.com
SUMMARY:Free webinar: How are the in vitro GARD™assays used in real life?
DESCRIPTION:Cases and applications for testing of skin and respiratory sensitizers\nJoin Dr Andy Forreryd from SenzaGen for a webinar on how the in vitro GARD assays are used across industries to test for skin and respiratory sensitizers. Andy will focus on the benefits of the GARD assays and walk you through several relevant examples of their applications. \nKey takeways\n\nHow the GARD assays are used for assessment of UVCBs\, hair dye products\, oil-based mixtures\, base formulations and medical devices.\nHow to differentiate between skin sensitizers and respiratory sensitizers by combining GARDskin and GARDair.\nHow to obtain potency classifications (GHS CLP) using GARDpotency.\n\n  \nAvailable on two occasions\nEU Time Zone | 25 Sept\, 15:00 CET | > Register here  \nUS Time Zone | 25 Sept\, 13:00 EDT| > Register here \n  \nAbout GARD\nHigh information\, high accuracy\nThe GARD tests are developed by combining genomic data from a relevant human cell type with machine learning to create a prediction model for identification of chemical sensitizers. This holistic\, high-information approach provides robust predictions with accuracies exceeding 90%. \nWith its high accuracy\, demonstrated human relevance and broad applicability\, the GARD assays can support your unique chemical testing requirements. \nAvailable GARD assays \n\nSkin sensitization: GARDskin\, GARDskin Medical Device NEW!\nPotency classification: GARDpotency\nRespiratory sensitization: GARDair\n\n  \n  \n  \n 
URL:https://senzagen.com/event/webinar-how-are-the-in-vitro-gardassays-used-in-real-life/
LOCATION:Available on two occasions\, EU Time Zone | 11:00 CET\, US Time Zone | 11:00 EDT
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2018/11/Webinar_Logo.jpg
END:VEVENT
END:VCALENDAR